Multivalent meningococcal derivatized polysaccharide-protein conjugates and corresponding vaccines

Details for Australian Patent Application No. 2004240558 (hide)

Owner Aventis Pasteur, Inc.

Inventors Ryall, Robert P.

Agent Spruson & Ferguson

Pub. Number AU-A-2004240558

PCT Pub. Number WO2004/103400

Priority 60/468,581 07.05.03 US

Filing date 7 May 2004

Wipo publication date 2 December 2004

International Classifications

A61K 039/095 Medicinal preparations containing antigens or antibodies - Neisseria

A61K 047/36 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/103400 Priority application(s): WO2004/103400

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004240561-A transgenic animal model for cancer and stem cells

2004240557-Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin